Concepts (132)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Electroencephalography | 7 | 2024 | 846 | 1.750 |
Why?
|
| Brain Injuries, Traumatic | 5 | 2025 | 322 | 1.460 |
Why?
|
| Thrombolytic Therapy | 2 | 2019 | 195 | 0.980 |
Why?
|
| Phosphopyruvate Hydratase | 2 | 2018 | 23 | 0.950 |
Why?
|
| Epilepsy, Post-Traumatic | 1 | 2025 | 13 | 0.930 |
Why?
|
| Stroke | 3 | 2019 | 1055 | 0.890 |
Why?
|
| Hypothermia, Induced | 2 | 2018 | 170 | 0.860 |
Why?
|
| Brain Injuries | 2 | 2025 | 703 | 0.730 |
Why?
|
| Heart Arrest | 2 | 2018 | 376 | 0.690 |
Why?
|
| Critical Care | 3 | 2025 | 684 | 0.680 |
Why?
|
| Pyramidal Tracts | 1 | 2020 | 32 | 0.620 |
Why?
|
| Cordotomy | 1 | 2020 | 14 | 0.620 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 1 | 2021 | 80 | 0.620 |
Why?
|
| Cerebral Angiography | 2 | 2016 | 106 | 0.610 |
Why?
|
| Terminology as Topic | 2 | 2025 | 223 | 0.600 |
Why?
|
| Cerebrovascular Circulation | 2 | 2025 | 484 | 0.570 |
Why?
|
| Neurologic Examination | 1 | 2018 | 187 | 0.520 |
Why?
|
| Hypovolemia | 1 | 2016 | 12 | 0.510 |
Why?
|
| Neurosurgical Procedures | 1 | 2020 | 320 | 0.510 |
Why?
|
| Hypoglossal Nerve Diseases | 1 | 2016 | 4 | 0.500 |
Why?
|
| Meningomyelocele | 1 | 2020 | 269 | 0.490 |
Why?
|
| Medulla Oblongata | 1 | 2016 | 24 | 0.490 |
Why?
|
| Coma | 1 | 2015 | 56 | 0.460 |
Why?
|
| Cerebral Hemorrhage | 1 | 2016 | 160 | 0.460 |
Why?
|
| Giant Cell Arteritis | 1 | 2015 | 49 | 0.410 |
Why?
|
| Intracranial Embolism | 1 | 2013 | 24 | 0.390 |
Why?
|
| Embolism, Air | 1 | 2013 | 21 | 0.390 |
Why?
|
| Status Epilepticus | 1 | 2015 | 156 | 0.380 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 3 | 2025 | 112 | 0.380 |
Why?
|
| Pain | 1 | 2015 | 429 | 0.380 |
Why?
|
| Body Weight | 1 | 2016 | 987 | 0.380 |
Why?
|
| Iatrogenic Disease | 1 | 2013 | 118 | 0.370 |
Why?
|
| Nervous System Diseases | 1 | 2015 | 394 | 0.330 |
Why?
|
| Anticonvulsants | 3 | 2025 | 363 | 0.320 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2016 | 2083 | 0.290 |
Why?
|
| Humans | 24 | 2025 | 130483 | 0.260 |
Why?
|
| Intracranial Pressure | 2 | 2025 | 217 | 0.240 |
Why?
|
| Aged | 9 | 2023 | 20918 | 0.240 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2016 | 162 | 0.230 |
Why?
|
| Prognosis | 4 | 2018 | 4880 | 0.230 |
Why?
|
| Monitoring, Physiologic | 2 | 2025 | 369 | 0.230 |
Why?
|
| Switzerland | 2 | 2015 | 16 | 0.210 |
Why?
|
| Neurophysiological Monitoring | 1 | 2024 | 37 | 0.200 |
Why?
|
| Intensive Care Units | 2 | 2024 | 521 | 0.200 |
Why?
|
| Middle Aged | 8 | 2020 | 28438 | 0.190 |
Why?
|
| Catheter-Related Infections | 1 | 2023 | 136 | 0.180 |
Why?
|
| Male | 12 | 2020 | 64488 | 0.170 |
Why?
|
| National Institute of Neurological Disorders and Stroke (U.S.) | 2 | 2025 | 13 | 0.170 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2022 | 71 | 0.170 |
Why?
|
| Lactates | 1 | 2021 | 81 | 0.170 |
Why?
|
| Homeostasis | 1 | 2025 | 715 | 0.170 |
Why?
|
| Child Abuse, Sexual | 2 | 2012 | 66 | 0.170 |
Why?
|
| Glasgow Coma Scale | 2 | 2025 | 203 | 0.160 |
Why?
|
| Cross Infection | 1 | 2023 | 332 | 0.160 |
Why?
|
| Spinal Nerve Roots | 1 | 2020 | 17 | 0.160 |
Why?
|
| Evoked Potentials, Motor | 1 | 2020 | 27 | 0.160 |
Why?
|
| Brain Concussion | 1 | 2022 | 248 | 0.150 |
Why?
|
| Monitoring, Intraoperative | 1 | 2020 | 128 | 0.150 |
Why?
|
| Brain Ischemia | 1 | 2022 | 268 | 0.150 |
Why?
|
| Eligibility Determination | 1 | 2019 | 36 | 0.150 |
Why?
|
| Urinary Tract Infections | 1 | 2023 | 329 | 0.150 |
Why?
|
| Female | 11 | 2020 | 70388 | 0.150 |
Why?
|
| Survivors | 1 | 2021 | 344 | 0.140 |
Why?
|
| Administration, Intravenous | 1 | 2019 | 168 | 0.140 |
Why?
|
| Registries | 2 | 2016 | 1607 | 0.140 |
Why?
|
| Critical Illness | 2 | 2025 | 617 | 0.130 |
Why?
|
| Iohexol | 1 | 2016 | 19 | 0.130 |
Why?
|
| Surveys and Questionnaires | 2 | 2024 | 4021 | 0.120 |
Why?
|
| Follow-Up Studies | 2 | 2018 | 5176 | 0.120 |
Why?
|
| Prospective Studies | 3 | 2022 | 6450 | 0.120 |
Why?
|
| Adult | 7 | 2018 | 31179 | 0.120 |
Why?
|
| Risk Factors | 3 | 2016 | 10953 | 0.120 |
Why?
|
| Periodicity | 1 | 2016 | 47 | 0.120 |
Why?
|
| Biomarkers | 1 | 2025 | 3388 | 0.120 |
Why?
|
| Physical Stimulation | 1 | 2015 | 37 | 0.120 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2017 | 175 | 0.110 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 6809 | 0.110 |
Why?
|
| Cross-Sectional Studies | 1 | 2024 | 3806 | 0.110 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2016 | 171 | 0.110 |
Why?
|
| Observation | 1 | 2015 | 40 | 0.110 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2025 | 136 | 0.110 |
Why?
|
| Hospitals, University | 1 | 2015 | 103 | 0.110 |
Why?
|
| Syndrome | 1 | 2016 | 1160 | 0.100 |
Why?
|
| Contrast Media | 1 | 2016 | 482 | 0.100 |
Why?
|
| Neuroimaging | 1 | 2016 | 383 | 0.100 |
Why?
|
| Criminals | 1 | 2012 | 18 | 0.090 |
Why?
|
| Pilot Projects | 1 | 2015 | 1448 | 0.080 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 1397 | 0.080 |
Why?
|
| Crime Victims | 1 | 2012 | 76 | 0.080 |
Why?
|
| Recurrence | 1 | 2015 | 1472 | 0.080 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 1880 | 0.080 |
Why?
|
| Cohort Studies | 2 | 2017 | 5081 | 0.070 |
Why?
|
| United States | 3 | 2025 | 11871 | 0.070 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 2298 | 0.070 |
Why?
|
| Epilepsy | 1 | 2016 | 863 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 1 | 2015 | 1290 | 0.070 |
Why?
|
| Algorithms | 1 | 2015 | 1676 | 0.070 |
Why?
|
| Seizures | 2 | 2022 | 874 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 3404 | 0.060 |
Why?
|
| Incidence | 1 | 2013 | 3326 | 0.060 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2025 | 157 | 0.050 |
Why?
|
| Animals | 1 | 2025 | 33862 | 0.050 |
Why?
|
| Time Factors | 1 | 2013 | 6200 | 0.050 |
Why?
|
| New York | 1 | 2022 | 68 | 0.050 |
Why?
|
| Cerebral Infarction | 1 | 2022 | 47 | 0.040 |
Why?
|
| Scalp | 1 | 2022 | 57 | 0.040 |
Why?
|
| Hospitals | 1 | 2023 | 441 | 0.040 |
Why?
|
| Medicare | 1 | 2023 | 438 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2016 | 17550 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2013 | 12843 | 0.030 |
Why?
|
| Sex Factors | 2 | 2012 | 1343 | 0.030 |
Why?
|
| Ataxin-2 | 1 | 2017 | 7 | 0.030 |
Why?
|
| DNA Repeat Expansion | 1 | 2017 | 38 | 0.030 |
Why?
|
| C9orf72 Protein | 1 | 2017 | 42 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2017 | 153 | 0.030 |
Why?
|
| International Cooperation | 1 | 2016 | 159 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2017 | 734 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2016 | 425 | 0.030 |
Why?
|
| Models, Genetic | 1 | 2017 | 747 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2017 | 1215 | 0.030 |
Why?
|
| Quality of Life | 1 | 2022 | 2082 | 0.020 |
Why?
|
| Exome | 1 | 2017 | 1073 | 0.020 |
Why?
|
| Adult Survivors of Child Abuse | 1 | 2012 | 13 | 0.020 |
Why?
|
| Proteins | 1 | 2017 | 1014 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2017 | 1714 | 0.020 |
Why?
|
| Family Conflict | 1 | 2011 | 17 | 0.020 |
Why?
|
| Personality | 1 | 2011 | 111 | 0.020 |
Why?
|
| Personality Disorders | 1 | 2011 | 175 | 0.020 |
Why?
|
| Age Factors | 1 | 2011 | 2838 | 0.010 |
Why?
|
| Adolescent | 2 | 2012 | 20737 | 0.010 |
Why?
|
| Young Adult | 1 | 2011 | 10010 | 0.010 |
Why?
|
| Child | 1 | 2012 | 26101 | 0.010 |
Why?
|